NDA

Role of QA in New Drug Development and Approval

Role of QA in New Drug Development and Approval

Introduction The development and approval of new drugs involve a complex process, requiring rigorous quality assurance (QA) measures. QA plays a vital role in ensuring the safety, efficacy, and compliance of new drugs. In this blog, we’ll explore the critical role of QA in new drug development and approval. Why ... Read More
FDA NDA Classification Codes

FDA NDA Classification Codes

Understanding New Drug Application (NDA) Classification Codes is crucial for setting clear regulatory and development timelines. These codes help the FDA categorize new drugs based on their relationship to previously approved therapies. The numerous acronyms used by the FDA, along with their distinct meanings, can be quite confusing. Beyond its ... Read More
Whether to Submit an ANDA or 505(b)(2) Application

Whether to Submit an ANDA or 505(b)(2) Application

(1) A โ€œstand-alone NDAโ€ is an application submitted under section 505(b)(1) and approved under section 505(c) of the FD&C Act that contains full reports of investigations of safety and effectiveness that were conducted by or for the applicant or for which the applicant has a right of reference or use. ... Read More
Comparison Between Generic and Branded Product Regulatory Filings

Comparison Between Generic and Branded Product Regulatory Filings

Generic and branded pharmaceutical companies both undergo regulatory filings as part of the drug approval process. While the overarching goal is to ensure safety and efficacy, there are distinct differences in the regulatory requirements and processes for generic versus branded medications. Regulatory Requirements Generic: Branded: Filing Process Generic: Branded: Timelines ... Read More
Estimated Time Frames for Obtaining FDA Authorization

Estimated Time Frames for Obtaining FDA Authorization

๐—•๐—ถ๐—ผ๐—น๐—ผ๐—ด๐—ถ๐—ฐ๐˜€ The approval timeline for a biologic can vary depending on the complexity of the product and the data required to support its safety and effectiveness. ๐—ฃ๐—ฟ๐—ฒ-๐—œ๐—ก๐—— ๐—ฑ๐—ฒ๐˜ƒ๐—ฒ๐—น๐—ผ๐—ฝ๐—บ๐—ฒ๐—ป๐˜: 1-2 years๐—œ๐—ก๐——: 1-2 years๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐˜๐—ฟ๐—ถ๐—ฎ๐—น๐˜€: 3-7 years๐—•๐—Ÿ๐—” ๐˜€๐˜‚๐—ฏ๐—บ๐—ถ๐˜€๐˜€๐—ถ๐—ผ๐—ป: 6 months๐—™๐——๐—” ๐—ฟ๐—ฒ๐˜ƒ๐—ถ๐—ฒ๐˜„: 6-12 months๐—ง๐—ผ๐˜๐—ฎ๐—น ๐—ฎ๐—ฝ๐—ฝ๐—ฟ๐—ผ๐˜ƒ๐—ฎ๐—น ๐˜๐—ถ๐—บ๐—ฒ: 5-10 years ๐—•๐—ถ๐—ผ๐˜€๐—ถ๐—บ๐—ถ๐—น๐—ฎ๐—ฟ๐˜€ The approval timeline for ... Read More
Types of FDA Applications for Drugs and Biologics

Types of FDA Applications for Drugs and Biologics

FDA

The Electronic Common Technical Document (eCTD) is the standard, accepted electronic format for the following submission types: An eCTD publishing tool is recommended to automatically create the eCTD sequence folder and file structure. FDA does not recommend specific tool vendors, however, they can be located via internet search. For information ... Read More
How the ICH Quality Guidelines Fit Into the Drug Development Process

How the ICH Quality Guidelines Fit Into the Drug Development Process

The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) has developed a set of quality guidelines that are crucial for the safety, efficacy, and quality of pharmaceutical products. Here’s how these guidelines fit into the different phases of drug development: Preclinical Development Clinical Development Registration ... Read More
Different Phases of Clinical Trials

Different Phases of Clinical Trials

Pre-clinical (or laboratory) Studies Clinical trials are done only after preclinical findings suggest that the new drug or treatment is likely to be safe and will work in people. Pre-clinical studies, also called laboratory studies, include: Cell Studies Animal studies Phase 0 Studies The IND application must contain certain information, ... Read More